Scottish Biopharma Company’s state-of-the-art technology attracts £730k in fresh investment
Scottish biopharmaceutical company Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding aimed at further developing its state-of-the-art therapeutic and diagnostic technology and setting up fresh success in 2024. The funding round which will be split across two tranches has been supported by new and existing investors. These include co-founder Dr Celestine Santosh, InnoScot Health, Scottish Enterprise, […]









